Add time:08/14/2019         Source:sciencedirect.com

BackgroundThe REDUCE-IT study demonstrated that 4 g/day of eicosapentaenoic acid (EPA) ethyl esters (icosapent ethyl, IPE) reduced risk for major cardiovascular events by 25% in statin-treated patients with residual hypertriglyceridemia. How this treatment affected red blood cell (RBC) EPA and docosahexaenoic acid (DHA) levels (i.e., the omega-3 index, O3I) was not reported, but effects on plasma EPA concentrations were.

We also recommend Trading Suppliers and Manufacturers of Acid Red 226 (cas 12269-99-7). Pls Click Website Link as below: cas 12269-99-7 suppliers